Professor Farooqi who has been announced as the recipient of the 2024 Outstanding Clinical Investigator Award from the Endocrine Society.
She joins 14 other leading endocrinologists worldwide who have won prestigious 2024 Laureate Awards, the top honours in the field.
The Outstanding Clinical Investigator Award honours an internationally recognised clinical investigator who has contributed significantly to understanding the pathogenesis and therapy of endocrine and metabolic diseases. As a Clinical Scientist and Professor of Metabolism and Medicine, Sadaf’s research focusses on the fundamental mechanisms that control human energy homeostasis.
The citation from the Endocrine Society goes on to say:
Sadaf Farooqi discovered the first genes whose disruption causes severe obesity and established that the principal driver of obesity is a failure of the central control of appetite. In children with congenital leptin deficiency treated with recombinant leptin, she showed that leptin reduced hyperphagia, permitted the onset of puberty at an appropriate developmental stage, and reversed T cell mediated immune dysfunction. Sadaf has held roles within the Endocrine Society, including Associate Editor of The Journal of Clinical Endocrinology & Metabolism and she is a member of the Society’s Annual Meeting Steering Committee. She also participates in advocacy efforts to raise more awareness around weight stigma and obesity as a disease.
Established in 1944, the Endocrine Society’s Laureate Awards recognise the highest achievements in the endocrinology field, including groundbreaking research and innovations in clinical care. The Endocrine Society will present the awards to the winners at ENDO 2024, the Society’s annual meeting.
